|
|
|
RNews Digest, 16 March 2012
EditorsNote News and perspectives important to RNs and the profession of nursing, gathered from sources around the world.
|
|
By
|
|
|
|
|
Page Content Professional development: Nurses on boards American Journal of Nursing, Susan B. Hassmiller, March 2012 While nurses have leadership roles in many health care venues, they remain largely overlooked for the highest level of organizational leadership: board positions.
Nursing Research and Practice, Patricia Pittman & Benjamin Williams, 2012
Currently, 16 states and the District of Columbia permit advanced practice registered nurses to practice independently of physicians, allowing them to perform functions such as diagnosing and prescribing under their own authority within the primary care setting.
Healthcare consumers think higher cost means better quality NurseZone, 13 March 2012 Amid calls for better price transparency, U.S. healthcare consumers still equate cost with quality, according to a study in Health Affairs. The study found that when asked to choose a provider based only on cost, American consumers pick the more expensive option.
The politics of staffing Advance for Nurses, Pam Chwedyk, 12 March 2012 In 2011, no fewer than 15 states introduced nurse staffing bills into their legislatures. And, according to the American Nurses Association, 11 states introduced staffing legislation in the first two months of 2012 alone.
RN Central, Jennifer Olin, 15 March 2012
Scrubs, Terry Cralle, 13 March 2012
Debate grows over colorectal cancer screenings San Francisco Chronicle, Victoria Colliver, 11 March 2012 A colonoscopy, a dreaded medical procedure for people 50 and older, is the best, one-shot way to screen and detect colon cancer for now, most health professionals agree. But an increasing number of experts are beginning to voice support for alternative methods.
Column: Treat patients as individuals and not as numbers USA Today, James Stacey Taylor, 14 March 2012 Imagine the following scenario. Shocked by a devastating diagnosis of a rare blood cancer, your spirits are lifted when it's announced that a new medicine could treat your disease and give you a new lease on life. But before you can begin treatment, you're informed by your insurer that the drug isn't cost-effective—that, in this case, the cost of the drug outweighs the value of your life. RNL
—Compiled by Jane Palmer, assistant editor,
Reflections on Nursing Leadership
Published , Vol. 38, No. 1
|
|
|
To comment on this article please sign in.
|
|
|